Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-020020
Filing Date
2021-04-22
Accepted
2021-04-22 13:00:30
Documents
11
Period of Report
2021-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A rdus-def14a_20210609.htm DEF 14A 1981023
2 GRAPHIC g0iq2ztlsc2h000006.jpg GRAPHIC 75760
3 GRAPHIC g0iq2ztlsc2h000005.jpg GRAPHIC 3161
4 GRAPHIC g0iq2ztlsc2h000010.jpg GRAPHIC 304933
5 GRAPHIC g0iq2ztlsc2h000004.jpg GRAPHIC 8383
6 GRAPHIC g0iq2ztlsc2h000007.jpg GRAPHIC 99289
7 GRAPHIC g0iq2ztlsc2h000009.jpg GRAPHIC 296175
8 GRAPHIC g0iq2ztlsc2h000001.jpg GRAPHIC 3149
9 GRAPHIC g0iq2ztlsc2h000008.jpg GRAPHIC 8383
10 GRAPHIC g0iq2ztlsc2h000002.jpg GRAPHIC 5750
11 GRAPHIC g0iq2ztlsc2h000003.jpg GRAPHIC 3161
  Complete submission text file 0001564590-21-020020.txt   3096232
Mailing Address ATTN: CHIEF FINANCIAL OFFICER 950 WINTER STREET WALTHAM MA 02451
Business Address ATTN: CHIEF FINANCIAL OFFICER 950 WINTER STREET WALTHAM MA 02451 617-551-4000
Radius Health, Inc. (Filer) CIK: 0001428522 (see all company filings)

EIN.: 800145732 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35726 | Film No.: 21844132
SIC: 2834 Pharmaceutical Preparations